Interventional therapies for hepatocellular carcinoma

Hepatocellular carcinoma is the third most common cause of cancer-related death. In the past few years, staging systems have been developed that enable patients to be stratified into treatment algorithms in a multidisciplinary setting. Several of these treatments involve minimally invasive image-gui...

Descripción completa

Detalles Bibliográficos
Autores principales: Willatt, Jonathon M., Francis, Isaac R., Novelli, Paula M., Vellody, Ranjith, Pandya, Amit, Krishnamurthy, V.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335329/
https://www.ncbi.nlm.nih.gov/pubmed/22487698
http://dx.doi.org/10.1102/1470-7330.2012.0011
_version_ 1782230780728049664
author Willatt, Jonathon M.
Francis, Isaac R.
Novelli, Paula M.
Vellody, Ranjith
Pandya, Amit
Krishnamurthy, V.N.
author_facet Willatt, Jonathon M.
Francis, Isaac R.
Novelli, Paula M.
Vellody, Ranjith
Pandya, Amit
Krishnamurthy, V.N.
author_sort Willatt, Jonathon M.
collection PubMed
description Hepatocellular carcinoma is the third most common cause of cancer-related death. In the past few years, staging systems have been developed that enable patients to be stratified into treatment algorithms in a multidisciplinary setting. Several of these treatments involve minimally invasive image-guided therapy that can be performed by radiologists.
format Online
Article
Text
id pubmed-3335329
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-33353292014-04-05 Interventional therapies for hepatocellular carcinoma Willatt, Jonathon M. Francis, Isaac R. Novelli, Paula M. Vellody, Ranjith Pandya, Amit Krishnamurthy, V.N. Cancer Imaging Review Hepatocellular carcinoma is the third most common cause of cancer-related death. In the past few years, staging systems have been developed that enable patients to be stratified into treatment algorithms in a multidisciplinary setting. Several of these treatments involve minimally invasive image-guided therapy that can be performed by radiologists. e-Med 2012-04-05 /pmc/articles/PMC3335329/ /pubmed/22487698 http://dx.doi.org/10.1102/1470-7330.2012.0011 Text en © 2012 International Cancer Imaging Society
spellingShingle Review
Willatt, Jonathon M.
Francis, Isaac R.
Novelli, Paula M.
Vellody, Ranjith
Pandya, Amit
Krishnamurthy, V.N.
Interventional therapies for hepatocellular carcinoma
title Interventional therapies for hepatocellular carcinoma
title_full Interventional therapies for hepatocellular carcinoma
title_fullStr Interventional therapies for hepatocellular carcinoma
title_full_unstemmed Interventional therapies for hepatocellular carcinoma
title_short Interventional therapies for hepatocellular carcinoma
title_sort interventional therapies for hepatocellular carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335329/
https://www.ncbi.nlm.nih.gov/pubmed/22487698
http://dx.doi.org/10.1102/1470-7330.2012.0011
work_keys_str_mv AT willattjonathonm interventionaltherapiesforhepatocellularcarcinoma
AT francisisaacr interventionaltherapiesforhepatocellularcarcinoma
AT novellipaulam interventionaltherapiesforhepatocellularcarcinoma
AT vellodyranjith interventionaltherapiesforhepatocellularcarcinoma
AT pandyaamit interventionaltherapiesforhepatocellularcarcinoma
AT krishnamurthyvn interventionaltherapiesforhepatocellularcarcinoma

Ejemplares similares